Intelligent Bio Solutions Inc.
NASDAQ: INBS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Harry Simeonidis
- Employees
- 50
- Headquarters
- New York City, United States
- IPO year
- 2020
- Market cap
- $1.4M
- Website
- https://gbs.inc
Loading INBS…
Loading profile data…Frequently asked questions about INBS
What does Intelligent Bio Solutions Inc. (INBS) do?
Intelligent Bio Solutions Inc. operates as a life sciences firm focused on developing non-invasive, real-time monitoring and diagnostic solutions for both patients and their primary healthcare providers. A notable product in its portfolio is the Saliva Glucose Biosensor, an organic thin-film transistor designed to precisely measure glucose level...
Where does INBS trade?
Intelligent Bio Solutions Inc. (INBS) trades on the NASDAQ Capital Market.
What sector is INBS in?
Intelligent Bio Solutions Inc. (INBS) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Intelligent Bio Solutions Inc.?
Harry Simeonidis is the chief executive officer of Intelligent Bio Solutions Inc. (INBS).
Where is Intelligent Bio Solutions Inc. headquartered?
Intelligent Bio Solutions Inc. is headquartered in United States.
Does INBS pay a dividend?
Intelligent Bio Solutions Inc. (INBS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did INBS go public?
Intelligent Bio Solutions Inc. (INBS) completed its initial public offering in 2020.